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ABSTRACT The database of drug compounds and human proteins plays a very important role in idenধfying the protein
target and the compound in drug discovery. Recently, a network pharmacology approach was established by updaধng the re-
search paradigm from the current “one disease-one target-one drug” to a new “drug-target-disease network”. Ligand-protein
interacধons can be analyzed quanধtaধvely using simultaneous clustering and molecular docking. The docking method of-
fers the ability to quickly and cheaply predict the ligand-protein binding free energy (DG) in structure-based virtual screening.
Meanwhile, simultaneous clustering was used to find subgroups of compounds that exhibit a high correlaধon with subgroups
of target proteins. This study is focused on the interacধon between the 306 compounds from medicinal plants (brotowali
Tinospora crispa, ginger Zingiber officinale, pare Momordica charanࣅa, sembung Blumea balsamifera), syntheধc drugs (FDA-
approved) and the 21 significant human proteins associated with type 2 diabetes. We found that brotowali (B018), sembung
(S031), pare (P231), and ginger (J036, J033) were close to the syntheধc drugs and can possibly be developed as anধdiabeধc
drug candidates. Likewise, the proteins AKT1, WFS1, APOE, EP300, PTH, GCG, and UBC which assemble each other and
which have a high associaধon with INS can be seen as target proteins that play a role in type 2 diabetes.
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1. Introducধon
Type 2 diabetes is a chronic disease characterized by the
body being unable to effectively produce insulin. World
Health Organization (2016) reported that the number of
people with diabetes has risen from 108 million in 1980
to 422 million in 2014. Diabetes is one of the leading
causes of death in the world and it has been rising more
rapidly in low-middle income countries such as Indonesia.
Indonesia was ranked one of the world’s top ten countries
for about 10 million adults with diabetes in 2015 (Inter-
national Diabetes Federation 2015) and was estimated to
reach 21.3 million by 2030 (World Health Organization
2016). This suggests that genetic risk factors, obesity, un-
healthy diet, and physical inactivity have also increased.
This case of diabetes now occurs not only in adults but
also in children and adolescents. Thus, diabetes problems
need to be handled seriously.
From a metabolic perspective, a disease occurs be-
cause the protein function is impaired. In order to make
the protein function normally, it needs to be treated with
drugs that contain several chemical compounds that can
influence or inhibit the activity of proteins or target net-
works. In recent years, a network pharmacology approach
was established by updating the research paradigm from
the current “one disease-one target-one drug” to a new
“drug-target-disease networks” (Yang et al. 2013). There-
fore, determination of the compounds that target the pro-
teins associated with a certain disease is crucial to under-
standing the molecular mechanisms in drug design.
There are several methods to investigate drug candi-
date at the molecular level. One of the most common uses
in computational technique (in silico) is molecular dock-
ing. Molecular docking offers the ability to predict quickly
and cheaply the ligand-protein interaction in structure-
based virtual screening which results in the binding free
energy (DG) scores. The binding free energy (DG) scores
show the bond strength between molecules or the mag-
nitude of ligand-protein interaction. Lalitha and Sripathi
(2011) have shown that Xylitol can be used for antidia-
betic using molecular docking. However, the compounds
isolated frommedicinal plants are safer andmore appropri-
ately used for metabolic and degenerative diseases (Greer
et al. 1994). Thus, in this study we use the ligand not only
from synthetic drugs but also from medicinal plants asso-
ciated with type 2 diabetes.
The ligand-protein interaction can be analyzed quan-
titatively by clustering method in order to find subgroups
Indones J Biotechnol 22(1), 2017, 43–48 | DOI 10.22146/ijbiotech.27334
www.jurnal.ugm.ac.id/ijbiotech
Copyright © 2017 THE AUTHOR(S). This arধcle is distributed under a
Creaধve Commons Aħribuধon-ShareAlike 4.0 Internaধonal license.
Rifai et al. Indonesian Journal of Biotechnology 22(1), 2017, 43–48
of compounds and subgroups of target proteins that exhibit
a high correlation in two-way data analysis. Most of the
standard clustering literature focuses on one-sided cluster-
ing algorithms, but in bioinformatics, it allows to deal with
sparse and high dimensional data matrices. Madeira and
Oliveira (2004) have been proposed a survey of simulta-
neous clustering algorithms on biological data. Simulta-
neous clustering is a method to avoid some limitations of
standard clustering approach. Simultaneous clustering is
more robust and more informative than standard cluster-
ing, as it involves rows and columns together. Thus, this
study is focused on the interaction between the compounds
of medicinal plants, synthetic drugs (FDA-approved) and
the human proteins associated with type 2 diabetes by us-
ing simultaneous clustering with molecular docking ap-
proach.
2. Materials and methods
2.1. Dataset preparaࣅon
The data of 287 compounds of four medicinal plants (Qo-
mariasih 2015) including 15 from brotowali (Tinospora
crispa), 173 from ginger (Zingiber officinale), 87 from
pare (Momordica charantia), 12 from sembung (Blumea
balsamifera) and 19 synthetic drugs were obtained from
PubChem (https://pubchem.ncbi.nlm.nih.gov) in .sdf for-
mat and were modeled using Marvinsketch in .pdb format.
In addition, the 21 human protein associated with type
2 diabetes (Usman 2016) sequences were obtained from
NCBI (https://www.ncbi.nlm.nih.gov) and were modeled
using SWISS-MODEL (http://swissmodel.expasy.org) in
.pdb format.
2.2. Molecular docking
Molecular docking is a method that predict the most fa-
vorable orientation of a ligand when interacting with a
protein to form a stable complex (Nogara et al. 2015).
Ligand-protein docking is an important type molecular
docking in modern structure-based drug design (Huang
and Zou 2010). There are two essential components in
ligand-protein docking method, namely the search algo-
rithm and the scoring function. The search algorithm is
responsible for searching through different ligand confor-
mations and orientations (poses) within a given target pro-
tein. The scoring function is responsible for estimating
the binding affinities of the generated poses, ranking them,
and identifying the most favorable binding modes of the
ligand to the given target. Before beginning the dock-
ing, drug-likeness for the ligand was analyzed by Lipin-
ski’s Rule parameters including hydrogen bond donors ≤
5, hydrogen bond acceptors ≤ 10, molecular weight ≤ 500
g/mol, and partition coefficient logP ≤ 5 (Lipinski et al.
2001). Molecules violating more than one of these rules
may delete because they have problems with bioavailabil-
ity. Optimization of ligand geometry was conducted by
using wash to improve the structure of the ligand and the
position of hydrogen atom. Minimization of ligand en-
ergy was conducted by using a modified Merck Molecular
Forcefield 94 (MMFF94) and gradient root mean square
(RMS) 0.001 kkal/Åmol. Whereas, optimization of pro-
tein geometry was conducted by adding polar hydrogens,
protonation, and partial charges. Minimization of protein
energy was conducted using Merck Molecular Forcefield
94x (MMFF94x) and solvation in gas phase with fixed
charges, then minimize with gradient root mean square
(RMS) 0.05 kkal/Åmol. Ligand-protein docking process
used placement Triangle Matcher with retain 5. Then,
scoring function used London dG, refinement is Forcefield
with retain 1. Molecular docking produces a binding free
energy (DG). Thermodynamically, the ligand-protein in-
teraction occurs when it produces DG < 0. The smaller
values of DG, the ligand-protein bonds are more stable or
ligand-protein interactions are stronger.
2.3. Simultaneous clustering
Simultaneous clustering performs clustering in the two
dimensions simultaneously (Charrad and Ahmed 2011).
Simultaneous clustering, usually called by bi-clustering,
co-clustering, two-way clustering, or block clustering, is
an important technique to find sub-matrices. The sub-
matrices are subgroups of rows and subgroups of columns
that exhibit a high correlation in two-way data analysis. In
this study, singular value decomposition (SVD) approach
was applied for simultaneous clustering analysis. IfX is an
n pmatrix with n observations in a row and p variables
in column then the SVD is (Jolliffe 2002)
X = ULAT (1)
where U and A are n r and p r orthonormal column
matrices (UTU = ATA = Ir), L is r r diagonal matrix,
and r is the rank of X.
The SVD in the dimension reduction is relevant to
PCA in several respects. The columns of the matrices U
and A are eigenvectors of the matrices XXT and XTX, re-
spectively, and the decreasing non-negative entries l1/21 
l1/22  ...  l1/2r in the diagonal matrix L are square roots
of the non-zero eigenvalues of XXT and also of XTX. We
denote the ith columns of the matrices U and A by ui and
ai, respectively. The vectors ui and ai are called the left
and right singular vectors of X, and the values li are called
the singular values.
The SVD in clustering is a generalization of the al-
gorithm shows a transformation that permit us to get
two matrices from one matrix. Now define La , for
0  a  1, as the diagonal matrix whose elements are
la/21 , l
a/2
2 , . . . , l
a/2
r with a similar definition for L1 a, and
let G = ULa,HT = L1 aAT . Then
GHT = ULaL1 aAT = ULAT = X (2)
We used a = 1
2
so G = UL0.5 and HT = L0.5AT . G
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and H matrices represent the information of compounds
and proteins, respectively. Then, these matrices were ana-
lyzed by hierarchical clustering and plotted in heat map
with two-dimensional dendrograms simultaneously. G
matrix produced a column-side dendrogram andH matrix
produced a row-side dendrogram, or reversed. A heat map
is a literal way of visualizing the binding free energy (DG)
scores with colored cells. We used the Euclidean distance
and linkage method both for clustering of compounds and
proteins to built a two-dimensional dendrograms.
Euclidean distance: the usual square distance between
two vectors, is given by:
d(x, y) = (
d
å
j=1
(xj   yj)2)
1
2 (3)
Single linkage: the distance Dij between two clusters Ci
and Cj is the minimum distance between two points x and
y, with x 2 Ci and y 2 Cj, is given by:
Dij = min
x2Ci ,y2Cj
d(x, y) (4)
Complete linkage: the distance Dij between two clusters
Ci and Cj is the maximum distance between two points x
and y, with x 2 Ci and y 2 Cj, is given by
Dij = max
x2Ci ,y2Cj
d(x, y) (5)
Average linkage: the distance Dij between two clusters
Ci and Cj is the mean of the distance between the pair of
points x and y, where x 2 Ci and y 2 Cj, is given by:
Dij = å
x2Ci ,y2Cj
d(x, y)
ni  nj (6)
Ward: the total within-cluster sum of square (SSE) is com-
puted to determine the next two groups merged at each
step of algorithm, where xj is multivariate measurement
associated with the jth object and x¯ is the mean of all the
object, is given by:
SSE =
N
å
j=1
(xj   x¯)0(xj   x¯) (7)
Furthermore, we compared the performance of linkage
method using heat maps against a number of reasonable
benchmarks.
3. Results and discussion
The results of drug likeness test showed that out of 306
compounds, 199 compounds (185 from medicinal plants
and 14 from synthetic drugs) satisfied the Lipinski’s Rule
properties. The boxplot of DG scores from medicinal
plant and synthetic drug compounds in Figure 1 are not
greatly different. Although the mean of ligand-protein
interaction from medicinal plants is lower than synthetic
drugs, some of medicinal plant compounds produce the
lowest DG scores < -15 kJ/mol. The most stable binding
complex or strongest interaction for medicinal plants is
-16.97 kJ/mol (J156 and INS) whereas for synthetic drugs
is -14.56 kJ/mol (DB11 and INS). Therefore, somemedici-
nal plants have a better stability than synthetic drugs and it
can possible be developed as antidiabetic drug candidates.
The relative position of the compounds based on the
target proteins can be described by plot PCs (Figure 2).
The plot of first two PCs in Figure 2 shows that compounds
tend to gather in quadrant III and outside quadrant III. The
synthetic drug compounds (red color) spread in quadrants
I, II, and III. In quadrant I, there is one synthetic drug com-
pound that is close to pare (purple color) and ginger (black
color). In quadrant II, there are 4 synthetic drug com-
pounds that tend to gather with ginger and sembung (green
color). In quadrant III, there are many synthetic drugs that
are close to each other with some medicinal plant com-
pounds of brotowali (blue color), ginger, pare, and sem-
bung. In quadrant IV, there is no synthetic drug com-
pounds. The first two PCs explain 87.29% of the total vari-
ance. This plot is an exploration of the compound group-
ing based on PCs of target proteins. Furthermore, the clus-
ter analysis was performed using simultaneous clustering.
The index values of cluster validity show that the best
number of clusters for the compounds is two clusters (Ta-
ble 1) and for the proteins is two clusters (Table 2). The
hierarchical method that produce the most two clusters
for the compounds is complete linkage method, whereas
for the proteins are complete linkage and Ward method.
Therefore, the best hierarchical method used for the simul-
taneous clustering is complete linkage method.
The two-dimensional dendrogram generated by com-
plete linkage method in Figure 3 is trimmed into two clus-
ters both in row (protein) and column (compound). The
strong ligand-protein interactions (light yellow colors) are
found horizontally on the right-side (quadrant I and IV)
and vertically on the up-side (quadrant I and II). In addi-
tion, 13 synthetic drug compounds are more commonly
Medicinal.Plant Synthetic.Drug
0
5
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ta
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FIGURE 1 Boxplot of ligand-protein interacধon (DG) scores.
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TABLE 1 Cluster validity of ligand.
Validity Index Linkage Method Number of clusters (compound)
2 3 4 5 6 7 8 9 10
CH Single 4.75a 3.82 4.26 3.87 3.77 3.67 3.53 3.36 3.30
Complete 15.18a 9.59 7.93 8.22 7.35 9.15 9.55 8.90 8.30
Average 4.75 3.95 3.62 3.38 4.04 3.77 3.57 3.41 3.64
Ward 26.25a 23.06 18.82 16.49 15.16 14.27 13.35 12.68 12.18
Pseudo t2 Single 0.21a 4.98 -0.12 0.47 0.22 0.05 -0.42 0.09 -0.21
Complete 3.88a -0.69 8.46 3.53 19.42 9.28 3.57 0.00 5.34
Average -1.62a 0.21 -0.11 6.31 -0.49 0.03 0.37 4.93 6.07
Ward 18.83 11.30 7.12a 8.76 6.82 7.68 5.24 -1.60 5.14
Frey Single 39.24 15.67 6.38a -0.40 1.23 4.72 8.82 2.33 3.99
Complete -1.38 -1.49 0.45 -0.69 -0.21 1.75 -0.14 -0.32 0.34
Average 30.17 14.95 12.84 6.02 6.33 5.57 5.43 4.84 3.27
Ward 0.07 0.82 0.35 2.10 0.68 -0.10 0.29 -0.14 0.26
Gap Single 0.52 0.53a 0.03 -1.24 -1.78 -2.17 -2.18 -2.45 -2.50
Complete -0.25a -1.05 -1.56 -1.95 -2.38 -2.52 -2.79 -2.96 -3.14
Average -0.39a -1.11 -1.74 -2.04 -2.43 -2.87 -3.09 -3.17 -3.34
Ward -0.33a -0.85 -1.46 -1.79 -2.20 -2.65 -2.77 -2.91 -3.07
a Index values that show the best number of clusters.
TABLE 2 Cluster validity of protein.
Validity Index Linkage Method Number of clusters (compound)
2 3 4 5 6 7 8 9 10
CH Single 2.49a 1.89 1.74 1.70 1.77 1.72 1.70 1.71 1.64
Complete 2.49a 1.91 1.76 1.96 1.89 1.84 1.79 1.78 1.76
Average 2.49a 1.89 1.74 1.98 1.89 1.81 1.77 1.74 1.69
Ward 2.49a 2.43 2.14 1.98 1.89 1.84 1.80 1.78 1.76
Pseudo t2 Single 0.00a 0.09 0.12 1.74 -0.36 -0.39 -0.38 0.00 -0.19
Complete 1.32a 0.08 2.26 0.00 -0.31 -0.27 -0.40 -0.48 1.21
Average 0.00a 0.09 2.30 -0.35 -0.27 -0.41 -0.50 -0.24 0.13
Ward 2.26a 0.08 0.00 1.39 -0.31 -0.40 -0.27 -0.48 -0.24
Frey Single 3.44 4.38 1.72 1.46 1.13a 0.85 0.53 2.71 0.72
Complete 22.79a -0.02 0.07 -0.09 0.17 0.14 0.19 0.29 0.58
Average 3.44 4.38 1.42a 0.83 0.69 0.71 0.82 0.73 0.58
Ward 2.70a 0.57 -0.03 4.35 0.17 0.23 0.09 0.29 0.17
Gap Single -0.12a -0.27 -1.82 -2.22 -2.64 -2.65 -3.03 -3.70 -4.06
Complete -0.30a -1.13 -2.30 -2.47 -2.80 -3.11 -3.48 -3.69 -4.05
Average -0.84a -1.60 -2.08 -2.54 -2.91 -3.12 -3.48 -3.70 -4.07
Ward -0.84a -1.55 -2.03 -2.54 -2.91 -3.14 -3.48 -3.69 -4.05
a Index values that show the best number of clusters.
found on the right-side and only one synthetic drug com-
pound on the left-side. Thus, we only focused on the
ligand-protein interactions in quadrant I.
There are 146 medicinal plants clustered with syn-
thetic drugs in quadrant I, those are 7 from brotowali, 95
from ginger, 23 from pare, and 8 from sembung. The
medicinal plants which close to synthetic drugs (DB12,
DB11, DB08, DB17) and (DB05) are (B018, S031) and
(P231), respectively. The synthetic drugs (DB01, DB13,
DB02, DB15, DB03, DB18) are close and clustered to
each other. Next, the medicinal plants (J036, J033) are
close to synthetic drugs (DB06, DB16).
The medicinal plants B018, S031, P231, J036, and
J033 which clustered with synthetic drugs in quadrant I,
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FIGURE 2 Two-dimensional plot of the compounds (medicinal plants and syntheধc drugs) based on the first two PCs of target proteins.
FIGURE 3 Heat map of ligand-protein interacধon by complete linkage method.
have the strongest interaction with protein APOE, IAPP,
INS, WFS1, and WFS1, respectively. The compound
P231 (Kuguacin Q) in pare that clustered with synthetic
drug DB05 (Glimepiride) has the lower DG scores with
protein INS than other proteins that is -10.30 kJ/mol, thus
pare can possible be developed as type 2 antidiabetic drug
candidates. Moreover, pare is known to have antihyper-
glycemic effects for both human and animals because it
contain alkaloids, flavonoids, saponins, and tannins (Lee-
laprakash et al. 2011).
Nevertheless, the light yellow-row cells in quadrant I
are more commonly found to the protein INS (Insulin). It
is also has shown by the highest DG scores in quadrant I is
for protein INS. That is, the protein INS is more targeted
by some compounds especially synthetic drugs than the
other proteins. The proteins that closest to protein INS are
AKT1, WFS1, APOE, EP300, PTH, GCG, dan UBC.
4. Conclusions
Based on molecular docking and simultaneously cluster-
ing analysis was obtained that medicinal plants such as
brotowali (B018), sembung (S031), pare (P231), and gin-
ger (J036, J033) are found close to synthetic drugs. Thus,
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those compounds especially pare (P231) that target the
protein insulin (INS) can possible be developed as type 2
antidiabetic drug candidates. Besides, the protein AKT1,
WFS1, APOE, EP300, PTH, GCG, dan UBC are found as
target proteins that play a role in type 2 diabetes.
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